Skip to main content
Clinical Trials/NL-OMON30895
NL-OMON30895
Not yet recruiting
Not Applicable

Microvasculopathy in Cerebral Small Vessel Disease - Cerebral small vessel disease

Academisch Medisch Centrum0 sites16 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
10007963
Sponsor
Academisch Medisch Centrum
Enrollment
16
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria cerebral large vessel disease group
  • TIA or stroke patients with one of the following:
  • \-clinically demonstrated loss of sensibility
  • \-clinically demonstrated loss of motor function;and including one or more of the following:
  • \-hemianopsia
  • \-neglect;and a carotid stenosis of more than 70% at the ipsilateral side.
  • Inclusion criteria cerebral small vessel disease group
  • Patients with a clinically established lacunar syndrome (see appendix A) and lacunar infarcts and/or leukoaraiosis on CT.

Exclusion Criteria

  • Exclusion criteria for both groups are:
  • \-Age of less than 18 years
  • \-Incapacitated subjects
  • \-A Modified Rankin Scale (MRS) \>3
  • \-Diabetes Mellitus type I and II
  • \-Iodine allergy
  • \-Hyperthyroidism
  • Exclusion criteria cerebral large vessel disease group
  • \-Lacunar infarcts and/or leukoaraiosis on CT
  • \-Indication of a cardiac source of intracranial embolism;Exclusion criteria cerebral small vessel disease group

Outcomes

Primary Outcomes

Not specified

Similar Trials